Oral sildenafil for severe pulmonary hypertension developing after ibuprofen use in a neonate

Indian Pediatrics

Volumn 53, Issue 4, 2016, Pages 349-350

  Rodríguez Castaño, Ma José ^a   Aleo, Esther ^a   Arruza, Luis ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Patent ductus arteriosus; Prematurity; Pulmonary vasodilators

Indexed keywords

ADRENALIN; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; IBUPROFEN; MAGNESIUM SULFATE; NITRIC OXIDE; SILDENAFIL; SURFACTANT; VASODILATOR AGENT;

AIRWAY PRESSURE; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; BRAIN ATROPHY; CASE REPORT; CESAREAN SECTION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ENTEROCOCCAL INFECTION; FLUID THERAPY; GESTATIONAL AGE; HEART LEFT RIGHT SHUNT; HIGH FREQUENCY VENTILATOR; HUMAN; HYPOTENSION; HYPOXEMIA; LUNG DYSPLASIA; MALE; MULTIPLE PREGNANCY; MYELINATION; NEWBORN; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PULMONARY HYPERTENSION; RESPIRATORY TRACT INTUBATION; RETROLENTAL FIBROPLASIA; THORAX RADIOGRAPHY; TREATMENT RESPONSE; CHEMICALLY INDUCED; HYPERTENSION, PULMONARY;

HUMANS; HYPERTENSION, PULMONARY; IBUPROFEN; INFANT, NEWBORN; MALE; SILDENAFIL CITRATE; VASODILATOR AGENTS;

EID: 84963722344     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-016-0852-x     Document Type: Article

References (9)

1. Gournay V, Savagner C, Thiriez G, Kuster A, Rozé JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet. 2002;359:1486–8.
2. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A. Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants. Med Wieku Rozwoj. 2005;9:335–54.
3. Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. CMAJ. 2006;174:1843–4.
4. Aranda JV, Clyman R, Cox B, van Overmeire B, Wozniak P, Sosenko I, et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen Llysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol. 2009;26:235–45.
5. Amendolia B, Lynn M, Bhat V, Ritz SB, Aghai ZH. Severe pulmonary hypertension with therapeutic L-lysine ibuprofen in 2 preterm neonates. Pediatrics. 2012;129:1360–3.
6. Sehgal A, Kumarshingri PS. Pulmonary hypertension in an infant treated with ibuprofen. Indian J Pediatr. 2013;80:697–9.
7. Bravo MC, Cordeiro M, Deiros L, Pérez-Rodríguez J. Lethal pulmonary hypertension associated with ibuprofen treatment in a very low birth weight infant. J Paediatr Child Health. 2014;50:85–6.
8. Porta NF, Steinhorn RH. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. Clin Perinatol. 2012;39:149–64.
9. Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2011;8:CD005494.